Literature DB >> 15340866

The Turkish version of the Bath Ankylosing Spondylitis Functional Index: reliability and validity.

Huseyin T E Ozer1, Tunay Sarpel, Bozkurt Gulek, Z Nazan Alparslan, Eren Erken.   

Abstract

The purpose of this study was to investigate the reliability and validity of the Turkish version of the Bath Ankylosing Spondylitis (AS) Functional Index (BASFI). The Turkish version of the BASFI was obtained after a process of translation and back-translation. Eighty-one consecutive patients meeting the 1984 New York criteria for AS were enrolled. Patients were evaluated and requested to complete the questionnaire at days 1 and 2 and on a third occasion between days 15-90. Reliability, reproducibility, validity and sensitivity to change of the Turkish version of the index were assessed. Each score correlated closely with the index score, with coefficients between 0.727 and 0.844. Reliability analysis showed a Cronbach's alpha score of 0.926. Correlations were found between all items of the BASFI and Schober's test (r=-0.258 to -0.531, p<0.001-0.05), occiput-to-wall distance (r=0.284 and 0.589, p<0.001-0.05), and finger-to-floor distance (r=0.334 to 0.613, p<0.001-0.01). The total index score was correlated with the number of nocturnal awakenings (r=0.515, p<0.001), Schober's test (r=-0.444, p<0.001), finger-to-floor distance (r=0.567, p<0.001), occiput-to-wall distance (r=0.535, p<0.001), chest expansion (r=-0.403, p<0.001), and the Dougados articular index (r=0.371, p<0.01). A good correlation was found between day 0 and 1 BASFI indices (r=0.765-0.917, p<0.001), showing good reproducibility of the index. The Turkish version of the BASFI showed reliability, reproducibility, and validity, confirming its utility in the research of AS in Turkey. However, sensitivity to changes due to drug therapy and/or rehabilitation remains to be determined.

Entities:  

Mesh:

Year:  2004        PMID: 15340866     DOI: 10.1007/s10067-004-0984-6

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  15 in total

Review 1.  Comparison of the Dougados Functional Index and the Bath Ankylosing Spondylitis Functional Index. A literature review.

Authors:  J Ruof; G Stucki
Journal:  J Rheumatol       Date:  1999-04       Impact factor: 4.666

2.  A comparative study of the usefulness of the Bath Ankylosing Spondylitis Functional Index and the Dougados Functional Index in the assessment of ankylosing spondylitis.

Authors:  A Spoorenberg; D van der Heijde; E de Klerk; M Dougados; K de Vlam; H Mielants; H van der Tempel; S van der Linden
Journal:  J Rheumatol       Date:  1999-04       Impact factor: 4.666

3.  Ankylosing spondylitis--the history of medical therapies.

Authors:  M A Khan
Journal:  Clin Exp Rheumatol       Date:  2002 Nov-Dec       Impact factor: 4.473

4.  Interleukin-6, acute phase reactants and clinical status in ankylosing spondylitis.

Authors:  Z N Tutuncu; A Bilgie; L G Kennedy; A Calin
Journal:  Ann Rheum Dis       Date:  1994-06       Impact factor: 19.103

5.  The Swedish version of the Bath ankylosing spondylitis functional index. Reliability and validity.

Authors:  H Cronstedt; A Waldner; C H Stenström
Journal:  Scand J Rheumatol Suppl       Date:  1999

6.  The Bath Ankylosing Spondylitis Patient Global Score (BAS-G).

Authors:  S D Jones; A Steiner; S L Garrett; A Calin
Journal:  Br J Rheumatol       Date:  1996-01

7.  Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria.

Authors:  S van der Linden; H A Valkenburg; A Cats
Journal:  Arthritis Rheum       Date:  1984-04

8.  Evaluation of the Finnish versions of the functional indices BASFI and DFI in spondylarthropathy.

Authors:  S Heikkilä; J V Viitanen; H Kautianen; M Kauppi
Journal:  Clin Rheumatol       Date:  2000       Impact factor: 2.980

9.  A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index.

Authors:  A Calin; S Garrett; H Whitelock; L G Kennedy; J O'Hea; P Mallorie; T Jenkinson
Journal:  J Rheumatol       Date:  1994-12       Impact factor: 4.666

10.  The Bath Ankylosing Spondylitis Radiology Index (BASRI): a new, validated approach to disease assessment.

Authors:  K MacKay; C Mack; S Brophy; A Calin
Journal:  Arthritis Rheum       Date:  1998-12
View more
  15 in total

1.  Translation and validation of the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) and the Bath Ankylosing Spondylitis Functional Index (BASFI) for use in Ukraine.

Authors:  Oleg Nadashkevich; Oleksiy Masyk
Journal:  Clin Rheumatol       Date:  2011-04-15       Impact factor: 2.980

2.  Postural deformities: potential morbidities to cause balance problems in patients with ankylosing spondylitis?

Authors:  Ece Çınar; Yeşim Akkoç; Hale Karapolat; Raika Durusoy; Gökhan Keser
Journal:  Eur J Rheumatol       Date:  2015-08-21

3.  Coping with Stress and Body Image in Patients with Ankylosing Spondylitis.

Authors:  Gökhan Sarisoy; Dilek Durmuş; Ömer Böke; Ferhan Cantürk; Ahmet Rıfat Şahin
Journal:  Noro Psikiyatr Ars       Date:  2014-06-01       Impact factor: 1.339

4.  Is magnetotherapy applied to bilateral hips effective in ankylosing spondylitis patients? A randomized, double-blind, controlled study.

Authors:  Yasemin Turan; Kevser Bayraktar; Fatih Kahvecioglu; Engin Tastaban; Elif Aydin; Imran Kurt Omurlu; Isil Karatas Berkit
Journal:  Rheumatol Int       Date:  2014-01-08       Impact factor: 2.631

5.  Reproducibility of the Bath Ankylosing Spondylitis Indices of disease activity (BASDAI), functional status (BASFI) and overall well-being (BAS-G) in anti-tumour necrosis factor-treated spondyloarthropathy patients.

Authors:  Ole R Madsen; Anne Rytter; Lonnie B Hansen; Charlotte Suetta; Charlotte Egsmose
Journal:  Clin Rheumatol       Date:  2010-03-21       Impact factor: 2.980

6.  Evaluation of the Turkish version of the Dougados functional index in ankylosing spondylitis.

Authors:  Huseyin T E Ozer; Tunay Sarpel; Bozkurt Gulek; Z Nazan Alparslan; Eren Erken
Journal:  Rheumatol Int       Date:  2005-03-02       Impact factor: 2.631

7.  Functional limitations due to axial and peripheral joint impairments in patients with ankylosing spondylitis: are focused measures more informative?

Authors:  Siddharth Bethi; Abhijit Dasgupta; Michael H Weisman; Thomas J Learch; Lianne S Gensler; John C Davis; John D Reveille; Michael M Ward
Journal:  Arthritis Care Res (Hoboken)       Date:  2013-04       Impact factor: 4.794

8.  Effects of a home-based exercise program on quality of life, fatigue, and depression in patients with ankylosing spondylitis.

Authors:  Dilek Durmus; Gamze Alayli; Erhan Cil; Ferhan Canturk
Journal:  Rheumatol Int       Date:  2008-11-05       Impact factor: 2.631

9.  Translation and validation of the Turkish version of the Ankylosing Spondylitis Quality of Life (ASQOL) questionnaire.

Authors:  M T Duruöz; L Doward; Y Turan; L Cerrahoglu; M Yurtkuran; M Calis; N Tas; S Ozgocmen; O Yoleri; B Durmaz; S Oncel; T Tuncer; O Sendur; M Birtane; F Tuzun; U Bingol; M Kirnap; G Celik Erturk; O Ardicoglu; A Memis; F Atamaz; R Kizil; C Kacar; G Gurer; K Uzunca; H Sari
Journal:  Rheumatol Int       Date:  2013-06-14       Impact factor: 2.631

10.  Evaluation of the Turkish version of the Bath Ankylosing Spondylitis Patient Global Score (BAS-G).

Authors:  Huseyin T E Ozer; Tunay Sarpel; Bozkurt Gulek; Z Nazan Alparslan; Eren Erken
Journal:  Clin Rheumatol       Date:  2006-02-14       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.